Have you been forced to switch your medication?

BC PharmaCare announced on September 5, 2019, that patients using Remicade® for inflammatory bowel disease (Crohn’s disease & ulcerative colitis) will have to switch to a biosimilar medication (Inflectra® or Renflexis®). PharmaCare claims it is because the biosimilars are cheaper, but the manufacturers of Remicade® have agreed to match the lower price, and PharmaCare refuses to allow patients to remain stable on their original biologic even though there is no financial benefit to the province. If you are one of the affected individuals, we want to help you. Please fill out the form below to share your story.

Since 1976, we have been providing educational resources, funding medical research, and advocating for GI and liver patients. We believe that your gastroenterologist should be allowed to prescribe the medication you need and that the government should not force you to switch.

Name*
First Last
Email*
Enter Email Confirm Email
Phone
City*
Message
Consent*
I consent to be contacted by the GI Society to obtain my story.
The information collected in this form is only used for the purposes of contact you for your personal story. It will not be shared with any third parties.

NOTICE: We received no pharma funding for this initiative.